MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Bilateral Pallidal Deep Brain Stimulation in Secondary Dystonia in Louis-Bar-Syndrome Patients – A Report of Two Cases-

    N. Warneke, I. Claus, V. Zentsch, W. Stummer (Münster, Germany)

    Objective: Deep Brain Stimulation (DBS) is an established treatment for various movement disorders, including primary dystonia. The effect in secondary dystonia is less well studied.…
  • 2025 International Congress

    Facial Synkinesis: Can It Have a Central Origin?

    J. Patino (Houston, USA)

    Objective: To describe a case of left facial synkinesis in a patient with a right middle cerebral artery stroke. Background: Facial synkinesis has been classically…
  • 2025 International Congress

    Real-World Experiences with VMAT2 Inhibitors in Pediatric Hyperkinetic Movement Disorders

    S. Manohar, J. Jacobe, R. Berger, J. Jankovic, M. Hull (Houston, USA)

    Objective: We review the real-world prescribing practices and patient experiences with VMAT2 inhibitors in children. Background: Vesicular monoamine transporter 2 (VMAT2) inhibitors are often prescribed…
  • 2025 International Congress

    Improving Automatic Speech Recognition for Speakers with Parkinson’s disease

    L. Ramig, M. Hasegawa-Johnson, C. Zwilling, H. Hodges, C. Mendes, H. Kim (Urbana, USA)

    Objective: 1. Obtain high-fidelity, speech data from 400 people with Parkinson’s (PWP) to train automatic speech recognition (ASR) systems.2. Develop and implement procedures to recruit,…
  • 2025 International Congress

    A Rare Case of Anti-Hu Opsoclonus-Myoclonus Syndrome after Immune Checkpoint Inhibitor Immunotherapy in a Patient with Small Cell Lung Cancer in Remission

    L. Hong, P. Atit, R. Patil, E. Sandberg, A. Makarova (Tampa, USA)

    Objective: To describe a case of anti-Hu/ANNA-1 Opsoclonus-Myoclonus syndrome (OMS) in a patient with small cell lung cancer (SCLC) after treatment with an immune checkpoint…
  • 2025 International Congress

    Safety, Feasibility, and Effects of Time-Restricted Eating in Early-Stage Huntington’s Disease: Preliminary Analysis of a Clinical Pilot Trial

    R. Wells, L. Neilson, A. Hiller (Portland, USA)

    Objective: Evaluate whether 12 weeks of daily time-restricted eating (TRE) appears safe and feasible in persons with early-stage Huntington's disease (HD) and explore its effects…
  • 2025 International Congress

    Successful Treatment of Hemifacial Spasm with Daxibotulinum Toxin A

    HS. Lee (Sacramento, USA)

    Objective: Botulinum toxin has been an effective and safe treatment option for hemifacial spasm. This is a report of 5 patients with successful treatment of…
  • 2025 International Congress

    A Dance with Sydenham, it’s Never Too Late to Tango

    M. Gomez Rodriguez, B. Cheon, S. Kenniff (Pembroke Pines, USA)

    Objective: Sydenham’s Chorea (SC) is a predominantly female childhood disorder characterized by irregular, fluid-like, involuntary movements. Here we present a case of isolated Sydenham’s chorea…
  • 2025 International Congress

    Autosomal Dominant DHDDS-Related Movement Disorder Treated with Primidone

    D. Dewey, M. Khalaf, M. Hoerth, M. Osundiji, J. Caviness, S. Chiu (Scottsdale, USA)

    Objective: To describe novel clinical features and treatment response in a patient with neurodevelopmental disorder due to variants in dehydrodolichol diphosphate synthetase (DHDDS). Background: DHDDS…
  • 2025 International Congress

    Leveraging a Smartphone-based Platform for Parkinson’s disease Real-world Research: A Multicenter, Cross-sectional Feasibility Assessment Study

    Z. Xu, Y. Tang, J. Wang (Shanghai, China)

    Objective: ​​​​​To evaluate the feasibility of a smartphone-based platform for remote patient-reported outcome (PRO) collection in Parkinson’s disease (PD) and explore its utility in identifying…
  • « Previous Page
  • 1
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley